Kewaunee Scientific (KEQU) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
7 Jul, 2026Executive summary
Annual meeting scheduled for August 26, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by August 25, 2026.
Voting matters and shareholder proposals
Election of three Class I directors: Thomas D. Hull III, David S. Rhind, and John D. Russell, all recommended by the board.
Ratification of Forvis Mazars, LLP as independent auditors for fiscal year 2027.
Advisory vote on executive compensation for the fiscal year ended April 30, 2026.
Proxies may vote on other business that arises during the meeting.
Board of directors and corporate governance
Board recommends all director nominees for election to Class I.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Kewaunee Scientific
- Annual meeting to vote on directors, auditor, and executive pay, with strong governance focus.KEQU
Proxy filing7 Jul 2026 - FY2026 revenue hit $282M, EBITDA up 112x, and debt reduced despite lower net earnings.KEQU
Q4 202627 Jun 2026 - Revenue and EBITDA rose, but net income fell on integration costs and higher expenses.KEQU
Q3 202625 Apr 2026 - Sales surged 46.8% to $70.1M, but net earnings dropped 18.7% amid integration costs.KEQU
Q2 202612 Dec 2025 - Q1 FY2026 sales and earnings surged, fueled by the Nu Aire acquisition and a strong backlog.KEQU
Q1 202610 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and governance policies.KEQU
Proxy Filing2 Dec 2025 - Annual meeting to vote on director, auditor, and executive pay, with a focus on governance and performance.KEQU
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, auditors, and executive pay, with board support for all.KEQU
Proxy Filing2 Dec 2025 - Annual meeting to vote on director, auditor, and executive pay, all board-recommended.KEQU
Proxy Filing2 Dec 2025